BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ER, estrogen receptor AND Prognosis
88 results:

  • 1. Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive pancreatic Ductal Adenocarcinoma.
    Matsumoto M; Shirai Y; Abe K; Futagawa Y; Haruki K; Furukawa K; Onda S; Hamura R; Tanji Y; Tsunematsu M; Shiozaki H; Okamoto T; Ikegami T
    Anticancer Res; 2024 Apr; 44(4):1695-1702. PubMed ID: 38537987
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
    Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
    Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ER-positive and BRCA2-mutated breast cancer: a literature review.
    Li PC; Zhu YF; Cao WM; Li B
    Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive analyses and experimental verification of NETs and an EMT gene signature for prognostic prediction, immunotherapy, and chemotherapy in pancreatic adenocarcinoma.
    Zhang J; Wang C; Yu Y
    Environ Toxicol; 2024 Apr; 39(4):2006-2023. PubMed ID: 38088494
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
    Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
    Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
    Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
    Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Shared decision making with Oncologists and Palliative care specialists (SOP) model help advanced pancreatic cancer patients reaching goal concordant care: A prospective cohort study.
    Tseng YL; Lin YC; Hsu WJ; Kang YC; Su HY; Cheng SY; Tsai JS; Chiu TY; Huang HL
    Cancer Med; 2023 Oct; 12(19):20119-20128. PubMed ID: 37740620
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    Shimagaki T; Sugimachi K; Mano Y; Tomino T; Onishi E; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Shimokawa M; Yoshizumi T; Toh Y
    PLoS One; 2023; 18(7):e0288033. PubMed ID: 37450554
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Persistent ER stress causes GPI anchor deficit to convert a GPI-anchored prion protein into pro-PrP via the ATF6-miR449c-5p-PIGV axis.
    Li J; Li S; Yu S; Yang J; Ke J; Li H; Chen H; Lu M; Sy MS; Gao Z; Li C
    J Biol Chem; 2023 Aug; 299(8):104982. PubMed ID: 37390992
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence.
    Nishimagi A; Kobayashi M; Sugimoto K; Kofunato Y; Sato N; Haga J; Ishigame T; Kimura T; Kenjo A; Kobayashi Y; Hashimoto Y; Marubashi S; Chiba H
    Clin Exp Med; 2023 Dec; 23(8):4985-4995. PubMed ID: 37285077
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Early Recurrence after Upfront Surgery for pancreatic Ductal Adenocarcinoma.
    Nappo G; Donisi G; Capretti G; Ridolfi C; Pagnanelli M; Nebbia M; Bozzarelli S; Petitti T; Gavazzi F; Zerbi A
    Curr Oncol; 2023 Mar; 30(4):3708-3720. PubMed ID: 37185395
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex.
    Ping D; Pu X; Ding G; Zhang C; Jin J; Xu C; Liu J; Jia S; Cao L
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194941. PubMed ID: 37146713
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.
    Zhang XP; Xu S; Gao YX; Zhao ZM; Zhao GD; Hu MG; Tan XL; Lau WY; Liu R
    Int J Surg; 2023 Apr; 109(4):785-793. PubMed ID: 36999776
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
    Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
    Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
    Bo Z; Chen B; Yang Y; Yao F; Mao Y; Yao J; Yang J; He Q; Zhao Z; Shi X; Chen J; Yu Z; Yang Y; Wang Y; Chen G
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2501-2513. PubMed ID: 36922449
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes.
    Tong Q; Qin W; Li ZH; Liu C; Wang ZC; Chu Y; Xu XD
    Cancer Med; 2023 Apr; 12(7):8526-8541. PubMed ID: 36645171
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
    Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PLPP2: Potential therapeutic target of breast cancer in PLPP family.
    Wang Z; Qi H; Zhang Y; Sun H; Dong J; Wang H
    Immunobiology; 2022 Nov; 227(6):152298. PubMed ID: 36332491
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chrysin-Induced G Protein-Coupled estrogen receptor Activation Suppresses pancreatic cancer.
    Lim HK; Kwon HJ; Lee GS; Moon JH; Jung J
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077069
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.